A detailed history of Winton Group LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Winton Group LTD holds 29,121 shares of CRL stock, worth $5.8 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
29,121
Previous 2,101 1286.05%
Holding current value
$5.8 Million
Previous $434,000 1221.66%
% of portfolio
0.44%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $5.08 Million - $6.63 Million
27,020 Added 1286.05%
29,121 $5.74 Million
Q2 2024

Aug 09, 2024

BUY
$206.39 - $268.73 $433,625 - $564,601
2,101 New
2,101 $434,000
Q2 2021

Aug 10, 2021

SELL
$294.17 - $371.65 $308,878 - $390,232
-1,050 Closed
0 $0
Q1 2021

Jul 21, 2021

SELL
$249.67 - $299.48 $284,623 - $341,407
-1,140 Reduced 52.05%
1,050 $304,000
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $486,180 - $553,237
2,190 New
2,190 $547,000
Q3 2020

Oct 30, 2020

SELL
$175.56 - $226.45 $935,383 - $1.21 Million
-5,328 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$118.84 - $189.72 $1.9 Million - $3.04 Million
-16,014 Reduced 75.04%
5,328 $929,000
Q1 2020

May 11, 2020

BUY
$98.9 - $178.34 $2.11 Million - $3.81 Million
21,342 New
21,342 $2.69 Million
Q4 2019

Feb 13, 2020

SELL
$126.05 - $152.76 $2.93 Million - $3.55 Million
-23,211 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$125.07 - $143.67 $5.13 Million - $5.9 Million
-41,046 Reduced 63.88%
23,211 $3.07 Million
Q2 2019

Jul 08, 2019

SELL
$123.4 - $148.55 $1.14 Million - $1.38 Million
-9,264 Reduced 12.6%
64,257 $9.12 Million
Q1 2019

May 13, 2019

SELL
$104.82 - $146.73 $1.51 Million - $2.12 Million
-14,433 Reduced 16.41%
73,521 $10.7 Million
Q4 2018

Feb 05, 2019

BUY
$105.09 - $137.23 $559,919 - $731,161
5,328 Added 6.45%
87,954 $9.96 Million
Q3 2018

Nov 02, 2018

BUY
$112.11 - $134.54 $9.26 Million - $11.1 Million
82,626 New
82,626 $0
Q2 2018

Aug 20, 2018

SELL
$102.37 - $117.25 $5.84 Million - $6.69 Million
-57,049 Closed
0 $0
Q1 2018

May 21, 2018

BUY
$98.19 - $115.2 $92,298 - $108,288
940 Added 1.68%
57,049 $0
Q4 2017

Feb 13, 2018

SELL
$100.43 - $118.09 $10.9 Million - $12.8 Million
-108,443 Reduced 65.9%
56,109 $6.14 Million
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $608,272 - $687,136
6,289 Added 3.97%
164,552 $17.8 Million
Q2 2017

Aug 17, 2017

BUY
N/A
158,263
158,263 $16 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.